Challenges in the treatment of convulsive status epilepticus

Highlights • There are news in the treatment of convulsive status epilepticus (CSE). • In pre-hospital setting, rapidity of administration is most important. • In established CSE phenytoin is not a first choice. • In refractory CSE midazolam and propofol are preferable. • Immunosuppression should be...

Full description

Saved in:
Bibliographic Details
Published inSeizure (London, England) Vol. 47; pp. 17 - 24
Main Authors Zaccara, Gaetano, Giannasi, Gianfranco, Oggioni, Roberto, Rosati, Eleonora, Tramacere, Luciana, Palumbo, Pasquale
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.04.2017
Subjects
Anaesthetics
Anti-epileptic drugs
Anticonvulsants - administration & dosage
Convulsive status epilepticus
Humans
Neurology
New onset-refractory status epilepticus
Refractory status epilepticus
Seizures - therapy
Status epilepticus
Status Epilepticus - therapy
Convulsive status epilepticus
Anti-epileptic drugs
Status epilepticus
Refractory status epilepticus
New onset-refractory status epilepticus
Anaesthetics
Online AccessGet full text

Cover

More Information
Summary:Highlights • There are news in the treatment of convulsive status epilepticus (CSE). • In pre-hospital setting, rapidity of administration is most important. • In established CSE phenytoin is not a first choice. • In refractory CSE midazolam and propofol are preferable. • Immunosuppression should be considered in refractory CSE of unknown origin.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1059-1311
1532-2688
DOI:10.1016/j.seizure.2017.02.015